Skip To The Main Content

Browse these ideas available for licensing that have the potential to improve lives while creating jobs to support and grow the region.


All technologies
 are listed as non-confidential technical summaries.

Technologies were generated by academic institutions, entrepreneurs, and corporations.

Click the Tech Search button below to have Whiteboard2Boardroom staff complete a personalized search for innovations to license from our research institution partners.

The most recent innovations from our partners are featured separately and organized by category. All listings are updated as new technology opportunities become available. 

For assistance in connecting with, or attaining further information on any of these technologies, please contact us.

A Novel Breast Tumor Imaging Agent

Inventors at the University of Missouri have developed a novel breast tumor imaging agent capable of imaging for accurate diagnosis and staging of distant breast metastases. The agent can help detect tumors even under 1 centimeter in size.

Background
Breast cancer is the second most common type of cancer among women globally. Every year 200,000 new cases are diagnosed worldwide and this number is increasing. According to latest data by the CDC, in 2015- the latest year for which incidence data are available, 242,476 new cases of Female Breast Cancer were reported, and 41,523 women died of Female Breast Cancer in the United States.

Modalities for screening/early diagnosis of breast cancer have evolved over the years. Scintimammography or molecular breast imaging is an upcoming modality and has shown excellent reproducibility for detecting breast carcinomas. The current invention is a novel radio-pharmacological SPECT agent that has shown promising results in mouse models.

Applications
- Primary breast tumors
- Metastatic breast tumors

Advantages
- This technology can detect primary as well as distant metastatic tumors of less than one centimeter diameter often missed by other imaging modalities.

Patent Status
Patent pending

State of Development
Preclinical. Cell and animal studies have been performed.

Additional Details

Owner

University of Missouri-Columbia

Intellectual Property Protection

Pending Patent



Interested? Request More Information